FTSE 250 movers: Hikma Pharmaceuticals hit by target price cut

17th Apr 2013 15:19

Hikma Pharmaceuticals was a heavy faller today after going ex-dividend and being hit by a target price cut from Jefferies, from 1,150p to 1,040p. The cut came after the group announced its plan to hold on to its global injectables business.Miners were under the weather as investors looked to invest in 'safer' stocks amid fears over global growth after the IMF slashed its forecasts to just 3.3% for 2013. Moneysupermarket.com rose after Westhouse Securities moved its target price from 195p to 210p and upgraded from neutral to add. Marston's climbed despite warning on operating profit, saying that it expects to reduce operating costs by around £3.0m per year, with about half of this amount benefiting the results for the second half of this year.FTSE 250 - RisersSpirent Communications (SPT) 126.50p +3.01%Laird (LRD) 213.60p +2.94%Marston's (MARS) 135.90p +2.64%Rank Group (RNK) 159.00p +2.58%Interserve (IRV) 483.10p +2.55%Thomas Cook Group (TCG) 117.90p +2.52%Betfair Group (BET) 794.00p +2.45%Dunelm Group (DNLM) 875.50p +2.34%Moneysupermarket.com Group (MONY) 190.00p +2.32%Petra Diamonds Ltd.(DI) (PDL) 110.20p +2.32%FTSE 250 - FallersFerrexpo (FXPO) 162.40p -6.45%Hikma Pharmaceuticals (HIK) 927.00p -5.89%Kazakhmys (KAZ) 326.30p -5.61%Morgan Advance Materials (MGAM) 250.00p -5.12%Lonmin (LMI) 261.80p -4.70%SVG Capital (SVI) 370.00p -4.34%Ophir Energy (OPHR) 389.00p -4.33%African Barrick Gold (ABG) 173.10p -4.15%Fenner (FENR) 368.20p -4.14%Salamander Energy (SMDR) 178.90p -4.02%NR